Healthcare -
Biotechnology - NASDAQ - US
$ 3.34
2.77 %
$ 213 M
Market Cap
-2.9
P/E
LRMR - CAPITAL EXPENDITURES
Capital Expenditures LRMR - Larimar Therapeutics, Inc.
-164 K
LAST VALUE
29.82%
2 YEAR CAGR
-8.71%
5 YEAR CAGR
-25.44%
10 YEAR CAGR